International Business Machines Corporation (IBM) is Attracting Investor Attention: Here is What You Should Know

07.04.25 15:00 Uhr

Werte in diesem Artikel
Aktien

208,10 EUR 0,70 EUR 0,34%

1,09 GBP -0,00 GBP -0,18%

Indizes

PKT PKT

37.965,6 PKT -349,3 PKT -0,91%

17.765,2 PKT -600,2 PKT -3,27%

1.498,5 PKT -50,4 PKT -3,25%

15.298,4 PKT -1.017,3 PKT -6,24%

2.444,6 PKT -1,5 PKT -0,06%

5.062,3 PKT -11,8 PKT -0,23%

IBM (IBM) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this technology and consulting company have returned -13% over the past month versus the Zacks S&P 500 composite's -12.1% change. The Zacks Computer - Integrated Systems industry, to which IBM belongs, has lost 16.8% over this period. Now the key question is: Where could the stock be headed in the near term?Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.IBM is expected to post earnings of $1.43 per share for the current quarter, representing a year-over-year change of -14.9%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.3%.The consensus earnings estimate of $10.79 for the current fiscal year indicates a year-over-year change of +4.5%. This estimate has remained unchanged over the last 30 days.For the next fiscal year, the consensus earnings estimate of $11.61 indicates a change of +7.7% from what IBM is expected to report a year ago. Over the past month, the estimate has remained unchanged.Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, IBM is rated Zacks Rank #2 (Buy).The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:12 Month EPSProjected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.For IBM, the consensus sales estimate for the current quarter of $14.44 billion indicates a year-over-year change of -0.2%. For the current and next fiscal years, $64.84 billion and $68.29 billion estimates indicate +3.3% and +5.3% changes, respectively.Last Reported Results and Surprise HistoryIBM reported revenues of $17.55 billion in the last reported quarter, representing a year-over-year change of +1%. EPS of $3.92 for the same period compares with $3.87 a year ago.Compared to the Zacks Consensus Estimate of $17.56 billion, the reported revenues represent a surprise of -0.05%. The EPS surprise was +5.09%.The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates just once over this period.ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.IBM is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about IBM. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report International Business Machines Corporation (IBM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: IBM und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Here

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Here

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu IBM Corp. (International Business Machines)

Wer­bung

Analysen zu IBM Corp. (International Business Machines)

DatumRatingAnalyst
12:36IBM HoldJefferies & Company Inc.
31.03.2025IBM HoldJefferies & Company Inc.
23.03.2025IBM NeutralJP Morgan Chase & Co.
30.01.2025IBM BuyGoldman Sachs Group Inc.
30.01.2025IBM SellUBS AG
DatumRatingAnalyst
30.01.2025IBM BuyGoldman Sachs Group Inc.
21.04.2020IBM OutperformCredit Suisse Group
19.07.2019IBM OutperformCredit Suisse Group
11.04.2019IBM OutperformCredit Suisse Group
10.12.2018Red Hat BuyMonness, Crespi, Hardt & Co.
DatumRatingAnalyst
12:36IBM HoldJefferies & Company Inc.
31.03.2025IBM HoldJefferies & Company Inc.
23.03.2025IBM NeutralJP Morgan Chase & Co.
24.10.2024IBM HoldJefferies & Company Inc.
01.10.2024IBM HaltenDZ BANK
DatumRatingAnalyst
30.01.2025IBM SellUBS AG
24.10.2024IBM SellUBS AG
19.07.2018IBM SellSociété Générale Group S.A. (SG)
12.01.2018IBM SellSociété Générale Group S.A. (SG)
17.07.2017IBM UnderweightBarclays Capital

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IBM Corp. (International Business Machines) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen